Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
CERo Therapeutics Holdings Inc (NASDAQ: CERO) closed the day trading at $3.31 down -22.84% from the previous closing price of $4.29. In other words, the price has decreased by -$22.84 from its previous closing price. On the day, 1.76 million shares were traded. CERO stock price reached its highest trading level at $4.4 during the session, while it also had its lowest trading level at $3.15.
Ratios:
For a better understanding of CERO, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.56 and its Current Ratio is at 0.56.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 13 ’24 when YK Bioventures Opportunities G sold 2,998,908 shares for $0.06 per share. The transaction valued at 179,934 led to the insider holds 13,005,169 shares of the business.
YK Bioventures Opportunities G sold 1,614,541 shares of CERO for $113,018 on Dec 12 ’24. The 10% Owner now owns 16,004,077 shares after completing the transaction at $0.07 per share. On Dec 11 ’24, another insider, YK Bioventures Opportunities G, who serves as the 10% Owner of the company, sold 1,343,801 shares for $0.08 each. As a result, the insider received 107,504 and left with 17,618,618 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CERO now has a Market Capitalization of 3989880 and an Enterprise Value of 10414255.
Stock Price History:
The Beta on a monthly basis for CERO is 0.44, which has changed by -0.9832828 over the last 52 weeks, in comparison to a change of 0.118204355 over the same period for the S&P500. Over the past 52 weeks, CERO has reached a high of $895.40, while it has fallen to a 52-week low of $4.27. The 50-Day Moving Average of the stock is -49.30%, while the 200-Day Moving Average is calculated to be -84.85%.
Shares Statistics:
Over the past 3-months, CERO traded about 152.31K shares per day on average, while over the past 10 days, CERO traded about 301830 shares per day. A total of 1.19M shares are outstanding, with a floating share count of 1.14M. Insiders hold about 5.48% of the company’s shares, while institutions hold 18.61% stake in the company. Shares short for CERO as of 1759190400 were 72184 with a Short Ratio of 0.47, compared to 1756425600 on 38006. Therefore, it implies a Short% of Shares Outstanding of 72184 and a Short% of Float of 6.1300002.
Earnings Estimates
Investors are keenly observing as 1 analysts analyze and rate. The current performance of CERo Therapeutics Holdings Inc (CERO) in the stock market.The consensus estimate for the next quarter is -$1.7, with high estimates of -$1.7 and low estimates of -$1.7.
Analysts are recommending an EPS of between -$15.39 and -$15.39 for the fiscal current year, implying an average EPS of -$15.39. EPS for the following year is -$3.7, with 1.0 analysts recommending between -$3.7 and -$3.7.
